drugset / Trial / NCT00004148

Vaccine Therapy in Treating Patients With Unresectable Metastatic Melanoma

NCT00004148

Phase 1 Completed 12 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

Phase I trial to study the effectiveness of vaccine therapy in treating patients who have unresectable metastatic melanoma. Vaccines may make the body build an immune response to kill tumor cells.

Timeline

Start
1999-10
Primary completion
2006-04
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject rV-B7.1 Vaccine Other

Indications